Cogent Biosciences, Inc. (COGT) NASDAQ

9.34

+0.09(+0.97%)

Updated at February 05 09:51AM

Currency In USD

Valuation

Market Cap468.38M
Enterprise Value434.01M
P/E Ratio-4.21
PEG Ratio-0.04
Price/Sales Ratio182.85
Price/Book Ratio3.24
Enterprise/Revenue168.68
Enterprise/EBITDA-3.67

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-43.36
Operating Margin-46.61

Management Effectiveness

Return On Assets-0.63
Return On Equity-0.71

Income Statement

Revenue0
Revenue/Share0.05
Gross Profit-3.59M
EBITDA-205.86M
Net Income-192.41M
Diluted EPS-2.42

Balance Sheet

Total Cash335.52M
Total Cash/Share3.05
Total Debt17.83M
Total Debt/Equity0.06
Current Ratio6.44
Book Value Per Share2.86

Price History

52-Week Change62.28
52-Week High12.61
52-Week Low5.37
Moving Average 50 Days8.53
Moving Average 200 Days9.17

Statistics

Average Volume1.66M
Shares Outstanding110.46M
% Held by Institutions110.6

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateNovember 09, 2020